Center warns of overuse and misuse of Covid drugs


New Delhi:

Warning against the overconsumption and misuse of COVID-19 drugs, the government on Wednesday urged people to take a rational approach to drugs used for the treatment of the coronavirus.

In a press conference, NITI Aayog (Health) member Dr. VK Paul expressed concern about the “misuse and misuse” of drugs.

“We are concerned that whatever medicine we give him should be used rationally, there should be no overuse. Last time we saw a very scary situation when the contribution of medicine was to a very large extent responsible for mucormycosis,” he said. .

“The use of steroids can increase the risk of mucormycosis. Steroids are very powerful life-saving drugs, but they also have side effects and they disrupt immunological protection, they disrupt many biochemical pathways, so this was a very big lesson…we were at that time but now we know so this is a plea that the general public should be aware that there is a set of rational treatments that are listed in national protocols – ayush and general protocol and we have to limit ourselves to that,” he added.

Dr Paul said these protocols were developed by top experts and we are genuinely concerned about the overuse of drugs in Covid treatment.

“For fever, we give paracetamol, and for cough, we can use Ayush syrup. This is also what we prescribed in the home care module. If the cough persists for more than three days , there is an inhaler called Budesonide, those are the only three things,” he said.

Other than that, gargle, rest, don’t overdo it, it comes at a cost, he added.

“When we also go to the hospital and there is a need for oxygen, then based on clinical judgment there is a drug – methylprednisolone or dexamethasone. Heparin is also given by doctors inside hospitals…there are also clear guidelines for remdesivir no need to give it at home – this has led to overuse, panic and misuse,” he said. he declares.

(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)


Comments are closed.